Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 26 Breast Neoplasms 21 Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 15 Head and Neck Neoplasms 13 Rectal Neoplasms 11 Colonic Neoplasms 11 Prostatic Neoplasms 8 Pancreatic Neoplasms 7 Mouth Neoplasms 6 Glioblastoma 6 Neuroblastoma 5 Neoplasm Metastasis 5 Esophageal Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Recurrence 4 Precancerous Conditions 4 Ovarian Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Liver Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Gliosarcoma 4 Carcinoma, Hepatocellular 4 Adenomatous Polyposis Coli 4 Sarcoma 3

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 3 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cisplatin 3 Capecitabine 3 vistusertib 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Technetium 2 Specimen Handling 2 Sirolimus 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × Celecoxib × Clear all

NCT04469530 2026-02-27

AflacST1903

Emory University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡